small molecule

SANSAC

ERYTHROMYCIN

Loss of exclusivity—loss of exclusivity
CompanyDOW PHARMACEUTICAL SCIENCES

Drug detail

Brand nameSANSAC
Active ingredientERYTHROMYCIN
Strength2%
Dosage formSOLUTION
RouteTOPICAL
ModalitySmall molecule
FDA approvalJanuary 1985
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.